• Home
  • Sildenafil citrate
    • List of Articles Sildenafil citrate

      • Open Access Article

        1 - Effects of Long-term administration of sildenafil citrate on serum markers of cardiac injury in the rats
        Zarini, E., Amouoghli Tabrizi, B. *, Fartashvand, M., Sadeghy, R. .
        Nowadays, sexual impotence due to increased heart disease, has led to rising in consumption ofsexual enhancing drugs. In heart failure, due to decreased blood supply to corpus cavernosum,complete erection does not occur, which can lead to sexual dissatisfaction. One of More
        Nowadays, sexual impotence due to increased heart disease, has led to rising in consumption ofsexual enhancing drugs. In heart failure, due to decreased blood supply to corpus cavernosum,complete erection does not occur, which can lead to sexual dissatisfaction. One of the mostimportant drugs which are used to treat this disorder is sildenafil citrate, a selective inhibitor oftype 5 cGMP. The purpose of this study was to evaluate the long-term side effects of this drugon serum biomarkers of cardiac injury in the rat. In this study, 20 male Wistar rats wererandomly assigned into 2 groups including: control and treatment. In treatment group, sildenafilcitrate use at a dose of 100 mg/kg for 30 consecutive days in oral rout and control group onlyreceived Distilled water. At the end of experiment, the serum levels of cardiac troponin I,creatine kinase- MB, lactate dehydrogenase and aspartate aminotransferase were measured. Theresults obtained showed that sildenafil citrate has protective effects on cardiac enzymes whichmay be in association with releasing of nitric oxide (NO). Manuscript profile
      • Open Access Article

        2 - Evaluation of cardiac injury biomarkers in serum following concomitant administration of sildenafil citrate with dextromethorphan and chlorpheniramine in rat
        Rasol Sadeghy B. Amouoghli Tabrizi majid fartashvand
        Sildenafil citrate is an inhibitor of the enzyme phosphodiesterase 5, dextromethorphan is an antitussive with weak opioid effects, and chlorpheniramine is a first-generation antihistamine. Since cardiovascular complications related to all three drugs have been reported, More
        Sildenafil citrate is an inhibitor of the enzyme phosphodiesterase 5, dextromethorphan is an antitussive with weak opioid effects, and chlorpheniramine is a first-generation antihistamine. Since cardiovascular complications related to all three drugs have been reported, the aim of this study was to evaluate the serum levels of cardiac damage index enzymes and tropovinin I following co-administration of sildenafil with dextromethorphan and chlorpheniramine. Forty male Wistar rats were studied in 8 groups, one control group and the rest in the treatment group; Drugs sildenafil citrate (100 mg / kg), dextromethorphan (20 mg / kg), chlorpheniramine (20 mg / kg), dextromethorphan + chlorpheniramine, sildenafil + dextromethorphan, sildenafil + chlorpheniramine, sildenafil + rosemethor + dextrometer , Received food. The results showed that administration of sildenafil to rats did not cause statistically significant changes in serum cardiac injury indices compared with the control group (p < 0.05); The amount of CK-MB also decreased compared to the control group. On the other hand, following administration of chlorpheniramine and dextromethorphan to rats, either alone or in combination, serum levels of AST, LDH and CK-MB increased statistically significantly. Administration of chlorpheniramine caused a significant increase in LDH (p < 0.01) and CK-MB (p < 0.001) compared to the control group and administration of dextromethorphan increased the activity of the studied enzymes which increased AST (p < 0.05). ) And CK-MB (p < 0.001) were significant. Co-administration of sildenafil with dextromethorphan and sildenafil with chlorpheniramine or all three together increased the activity of all three enzymes in the heart damage index. Manuscript profile